Rising Use of GLP-1 Receptor Agonists in Youth With Type 2 Diabetes: Study
A study published in Pediatrics journal revealed that the use of GLP-1 receptor agonists (GLP-1 RAs) in youth aged 10–17 years with type 2 diabetes increased from 10.9% in 2020…